Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01258231 · ClinicalTrials.gov registry record
Identification of Genomic Predictors of Adverse Events After Cardiac Surgery
A clinical trial of Heart Failure and Atrial Fibrillation, sponsored by Brigham and Women's Hospital.
- Recruiting
- Registry status
- 4,000
- Enrollment target
- 3
- Study locations
NCT01258231: Recruiting study of Heart Failure and Atrial Fibrillation, sponsored by Brigham and Women's Hospital.
NCT01258231 is a study of Heart Failure and Atrial Fibrillation that is actively recruiting participants, run by Brigham and Women's Hospital. The registered enrollment target is 4,000 participants, above the 2,039-participant average among 397 other Heart Failure trials with a reported enrollment target (96% higher). The trial reports 3 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01258231, a study of Heart Failure and Atrial Fibrillation, is actively recruiting participants, sponsored by Brigham and Women's Hospital.
- RECRUITING
- Registry status
- 4,000 participants
- Enrollment target
- 3
- Study locations
Study Summary
This study aims to identify genetic causes of adverse events after cardiac surgery, such as atrial fibrillation, myocardial infarction, renal dysfunction and heart failure. Patients undergoing heart surgery at Brigham and Women's Hospital and Texas Heart Institute are eligible to participate.
Primary Outcome
Data will be collected from electronic medical records; data points to be collected for this measurement include serum creatinine.
Conditions Studied
Study Locations (3)
Texas
- UT Southwestern Medical Center - Dallas
- Department Texas Heart Institute at St. Luke's Episcopal Hospital - Houston
Massachusetts
- Brigham and Women's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,000 participants |
| Start Date | 2000-08 |
| Est. Completion | 2030-08 |
What NCT01258231 shows while recruiting
NCT01258231 is an observational study that tracks outcomes without assigning an intervention. Its 4,000 participants enrollment target places it among the larger protocols in the corpus, above the 2,039-participant average among 397 other Heart Failure trials with a reported enrollment target (96% higher).
The record links to 5 conditions, with Heart Failure appearing as the primary indexed condition, and to 0 interventions.
NCT01258231 reports a single indexed study location in Texas, Massachusetts.
Frequently Asked Questions
What is clinical trial NCT01258231 about?
NCT01258231 is a clinical study titled "Identification of Genomic Predictors of Adverse Events After Cardiac Surgery". This study aims to identify genetic causes of adverse events after cardiac surgery, such as atrial fibrillation, myocardial infarction, renal dysfunction and heart failure. Patients undergoing heart surgery at Brigham and Women's Hospital and Texas Heart Institute are eligible to participate.
What is the current status of trial NCT01258231?
This trial is currently recruiting. The enrollment target is 4,000 participants. The study started on 2000-08. Estimated completion is 2030-08.
What conditions does trial NCT01258231 study?
This clinical trial studies the following conditions: Heart Failure, Atrial Fibrillation, Myocardial Infarction, Genetic Predisposition to Disease, Heart; Dysfunction Postoperative, Cardiac Surgery.
Who is sponsoring clinical trial NCT01258231?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01258231 being conducted?
This trial has 3 study locations across Massachusetts, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01258231's enrollment target sits among peer trials
4,000 28th of 397 higher than 369 of 397 other Heart Failure trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Heart Failure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII)
RECRUITING · NA
-
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
RECRUITING · NA
-
iCardia4HF: Multi-component mHealth Intervention for Patients With Heart Failure
RECRUITING · NA
-
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients with Heart Failure Who Are Intolerant or Not Eligible for Treatment with Steroidal Mineralocorticoid Receptor Antagonists
RECRUITING · Phase 3
-
Circulating Markers That Underlie the Transition From Compensated Hypertrophy to Heart Failure
RECRUITING
-
Integration of Telemedicine and Home-Based Cardiac Rehabilitation: Feasibility, Efficacy, and Adherence
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00227253 · 4,000 participants
Chromosome 18 Clinical Research Center
- NCT00811148 · 4,000 participants
Florida Center for Brain Tumor Research
- NCT00897117 · 4,000 participants
Collecting and Analyzing Tissue Samples From Patients Undergoing Surgery for Non-Small Cell Lung Cancer
- NCT00899301 · 4,000 participants
Collecting and Storing Tissue Samples From Women With or Without Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia